Pancreatic Cancer Research

ResearcherJilin UniversityActive in the last 2 years

Shuang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6828-5925; OpenAlex author ID A5100415925. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. Curcumin Inhibits the Development of Pancreatic Cancer by Targeting the circ_0079440/miR-522-3p/EIF4A1 Pathway. First author DOI 10.1007/s12013-024-01466-8↗
  2. USP10 activates the FAK pathway by stabilizing RIOK3 in pancreatic ductal adenocarcinoma Co-author DOI 10.21203/rs.3.rs-3941004/v1↗
  3. PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer. Co-author DOI 10.3389/fonc.2023.1217654↗
  4. Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and imm… Co-author DOI 10.3389/fendo.2022.1078424↗
  5. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma. Co-author DOI 10.1080/21655979.2021.1933868↗
  6. Circulating leptin and adiponectin levels in patients with pancreatic cancer. Co-author DOI 10.1097/cm9.0000000000001509↗
  7. The Key Genes of Chronic Pancreatitis which Bridge Chronic Pancreatitis and Pancreatic Cancer Can be Therapeutic Targets. Co-author DOI 10.1007/s12253-017-0217-3↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dong Shang · 3 shared papers, 2021–2023 · strength 0.49
  2. Biao Zhang · 3 shared papers, 2021–2023 · strength 0.49
  3. Xu Chen · 3 shared papers, 2021–2023 · strength 0.49
  4. Qihang Yuan · 3 shared papers, 2021–2022 · strength 0.46
  5. Changjiang Luo · 1 shared paper, 2025 · strength 0.30
  6. Ruiying Luo · 1 shared paper, 2025 · strength 0.30
  7. Huiyi Song · 1 shared paper, 2023 · strength 0.19
  8. Jiwei Liu · 1 shared paper, 2024 · strength 0.19
  9. Zhen Ning · 1 shared paper, 2024 · strength 0.19
  10. Rui Sun · 1 shared paper, 2024 · strength 0.19
  11. Henan Qin · 1 shared paper, 2024 · strength 0.19
  12. Peiyuan Yin · 1 shared paper, 2024 · strength 0.19
  13. Zhizhou Wang · 1 shared paper, 2022 · strength 0.16
  14. Hangyu Liu · 1 shared paper, 2022 · strength 0.16
  15. Dong Shang · 1 shared paper, 2022 · strength 0.16
  16. Lisha Li · 1 shared paper, 2018 · strength 0.10
  17. Yulin Li · 1 shared paper, 2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.